Across TCGA pan-cancer cohorts, RNU6-937P RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of RNU6-937P’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where RNU6-937P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNU6-937P is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

BRCA, STAD, and COAD are the cancer types where RNU6-937P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU6-937P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	Female	II,III,IV	+0.251	.001	6	view →
STAD	All	All	+0.371	.019	4	view →
COAD	All	All	+0.159	.022	2	view →
THCA	All	All	−0.152	.009	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: RNU6-937P RNA expression & survival · all RNU6-937P data types